Mild cognitive impairment associated with limbic and neocortical lewy body disease: A clinicopathological study

Brain

Volumn 133, Issue 2, 2010, Pages 540-556

  Molano, Jennifer ^a,b   Boeve, Bradley ^a,b   Ferman, Tanis ^a,b   Smith, Glenn ^a,b   Parisi, Joseph ^a,b   Dickson, Dennis ^a,b   Knopman, David ^a,b   Graff Radford, Neill ^a,b   Geda, Yonas ^a,b   Lucas, John ^a,b   Kantarci, Kejal ^a,b   Shiung, Maria ^a,b   Jack, Clifford ^a,b   Silber, Michael ^a,b   Pankratz, V Shane ^a,b   Petersen, Ronald ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Dementia; Dementia with Lewy bodies; Lewy body disease; Mild cognitive impairment; Neuropathology

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITIVE DEFECT; DEATH; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEWY BODY; LIMBIC SYSTEM; MALE; NEOCORTEX; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASOMNIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY; VISUAL HALLUCINATION;

EID: 77249163671     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp280     Document Type: Article

References (77)

1. American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 3rd edn., Rev Washington, DC: American Psychiatric Association; 1987.
2. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease.The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropatholo-gical Assessment of Alzheimer's Disease. Neurobiol Aging 1997; 18: S1-S2.
3. Albin R, Koeppe R, Chervin R, Consens F, Wernette K, Frey K, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000; 55: 1410-1412
4. Benton A, Hamsher Kd. Multilingual Aphasia Examination (Manual). Iowa City, IA: University of Iowa; 1978.
5. Boeve B, Dickson D, Olson E, Shepard J, Silber M, Ferman T, et al. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med 2007a; 8: 60-64
6. Boeve B, Silber M, Ferman T, Lucas J, Parisi J. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001; 16: 622-630
7. Boeve B, Silber M, Parisi J, Dickson D, Ferman T, Benarroch E, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003; 61: 40-45
8. Boeve B, Silber M, Saper C, Ferman T, Dickson D, Parisi J, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007b; 130: 2770-2788 (Pubitemid 350033955)
9. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, et al. Pathologic heterogeneity in clinically diagnosed corti-cobasal degeneration. Neurology 1999; 53: 795-800.
10. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-259
11. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 1997; 18: S85-8.
12. Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
13. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318: 121-134
14. Burke R, Dauer W, Vonsattel J. A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 2008; 64: 485-491
15. Caselli R, Chen K, Bandy D, Smilovici O, Boeve B, Osborne D, et al. A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. Sleep 2006; 29: 927-933
16. Dubois B, Albert M. Amnestic MCI or prodromal Alzheimer's disease. Lancet Neurol 2004; 3: 246-248
17. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus F, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder: Comparison with Parkinson's disease and controls. Brain 2000; 123: 1155-1160
18. Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003; 26: 507-512
19. Ferini-Strambi L, Di Gioia M, Castronovo V, Oldani A, Zucconi M, Cappa S. Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): Does the idiopathic form of RBD really exist? Neurology 2004; 62: 41-45
20. Ferman T, Boeve B, Smith G, Silber M, Lucas J, Graff-Radford N, et al. Dementia with Lewy bodies may present as dementia with REM sleep behavior disorder without parkinsonism or hallucinations. J Internat Neuropsychol Soc 2002; 8: 907-914
21. Ferman T, Smith G, Boeve B, Graff-Radford N, Lucas J, Knopman D, et al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin Neuropsychol 2006; 20.
22. Ferman T, Smith G, Boeve B, Ivnik R, Petersen R, Knopman D, et al. DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004; 62: 181-187
23. Ferman TJ, Boeve BF, Smith GE, Silber MH, Kokmen E, Petersen RC, et al. REM sleep behavior disorder and dementia: cognitive differences when compared with AD. Neurology 1999; 52: 951-957
24. Folstein M, Folstein S, McHugh P. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
25. Frigerio R, Fujishiro H, Ahn T, Josephs K, Maraganore D, Delledonne A, et al. Incidental Lewy body disease: Do some cases represent a pre-clinical stage of dementia with Lewy bodies? Neurobiol Aging 2009; Jun 25. [Epub ahead of print].
26. Fujishiro H, Ferman T, Boeve B, Smith G, Graff-Radford N, Uitti R, et al. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 2008; 67: 649-656
27. Gagnon J-F, Postuma R, Mazza S, Doyon J, Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 2006; 5: 424-432
28. Gwinn-Hardy K, Mehta ND, Farrer M, Maraganore D, Muenter M, Yen SH, et al. Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathologica 2000; 99: 663-672
29. Hughes A, Ben-Shlomo Y, Daniel S, Lees A. What features improve the accuracy of clinical diagnosis in Parkinson's disease? A clinicopatholo-gic study. Neurology 1992; 42: 1142-1146
30. Iranzo A, Molinuevo J, Santamaría J, Serradell M, Martí M, Valldeoriola F, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006; 5: 572-577
31. Ivnik R, Malec J, Smith G, Tangalos E, Petersen R. Neuropsychological tests' norms above age 55: COWAT, BNT, MAE Token, WRAT-R reading, AMNART, STROOP, TMT and JLO. Clin Neuropsychol 1996; 10: 262-278
32. Ivnik R, Malec J, Smith G, Tangalos E, Petersen R, Kokmen E, et al. Mayo's Older American Normative Studies: WAIS-R, WMS-R, and AVLT norms for ages 56-97. Clin Neuropsychol 1992; 6 (Suppl): 1-104.
33. Ivnik RJ, Smith GE, Lucas JA, Tangalos EG, Kokmen E, Petersen RC. Free and cued selective reminding test: MOANS norms. J Clin Exp Neuropsychol 1997; 19: 676-691
34. Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55: 484-489
35. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004; 62: 591-600.
36. Jellinger K, Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathol 2003; 105: 14-17. (Pubitemid 36789951)
37. Jicha G, Parisi J, Dickson D, Johnson K, Cha R, Ivnik R, et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 2006; 63: 674-681
38. Jicha G, Schmitt F, Abner E, Nelson P, Cooper G, Smith C, et al. Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging 2008; Nov 19. [Epub ahead of print].
39. Josephs K, Tsuboi Y, Cookson N, Watt H, Dickson D. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Arch Neurol 2004; 61: 1579-1584
40. Josephs K, Whitwell J, Duffy J, Vanvoorst W, Strand E, Hu W, et al. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology 2008; 70: 25-34.
41. Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, Smith GE, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 2000; 55: 210-217
42. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, et al. 1H MR spectroscopy in common dementias. Neurology 2004; 63: 1393-1398
43. Kaplan E, Goodglass H, Weintraub S. The Boston naming test. Boston: E. Kaplan & H. Goodglass; 1978.
44. Kokmen E, Smith G, Petersen R, Tangalos E, Ivnik R. The short test of mental status: correlations with standardized psychometric testing. Arch Neurol 1991; 48: 725-728
45. Lucas JA, Ivnik RJ, Smith GE, Bohac DL, Tangalos EG, Graff-Radford NR, et al. Mayo's older Americans normative studies: category fluency norms. J Clin Exp Neuropsychol 1998a; 20: 194-200.
46. Lucas JA, Ivnik RJ, Smith GE, Bohac DL, Tangalos EG, Kokmen E, et al. Normative data for the Mattis Dementia Rating Scale. J Clin Exp Neuropsychol 1998b; 20: 536-547
47. Mattis S. Dementia rating scale: professional manual. Odessa: Psychological Assessment Resources; 1988.
48. Mazza S, Soucy J, Gravel P, Michaud M, Postuma R, Massicotte J, et al. Assessing whole brain perfusion changes in REM sleep behavior disorder. Neurology 2006; 67: 1618-1622
49. McKeith I, Dickson D, Lowe J, Emre M, O'Brien J, Feldman H, et al. Dementia with Lewy bodies: diagnosis and management: Third report of the DLB Consortium. Neurology 2005; 65: 1863-1872
50. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944
51. Members of the Department of Neurology MC.Clinical Examinations in Neurology. St. Louis: Mosby-Year Book, Inc.; 1998
52. Mirra S, Heyman A, McKeel D, Sumi S, Crain B, Brownlee L, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486
53. Mori E, Shimomura T, Fujimori M, Hirono N, Imamura T, Hashimoto M, et al. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 2000; 57: 489-493
54. Morris J, Storandt M, Miller J, McKeel D, Price J, Rubin E, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58: 397-405. (Pubitemid 32217456)
55. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-2414
56. Neary D, Snowden J, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554
57. Olson E, Boeve B, Silber M. Rapid eye movement sleep behavior disorder: demographic, clinical, and laboratory findings in 93 cases. Brain 2000; 123: 331-339
58. Osterrieth P. Le test de copie d'une figure complexe. Arch Psychol 1944; 30: 206-356.
59. Petersen R. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194 (Pubitemid 39222988)
60. Petersen R, Parisi J, Dickson D, Johnson K, Knopman D, Boeve B, et al. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 2006; 63: 665-672
61. Postuma R, Gagnon J, Vendette M, Fantini M, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009; 72: 1296-1300
62. Reitan R. Validity of the trail-making test as an indication of organic brain damage. Percept Mot Skills 1958; 8: 271-276
63. Rey A. L'examen psychologique dan les cas d'encephalopathie trauma-tique. Arch Psychol 1941; 28: 286-340.
64. Rey A. L'Examen Clinique en Psychologie. Paris, France: Presses Universitaires de France; 1964.
65. Salmon D, Galasko D, Masliah E, Butters N, Thal L, Hansen L, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn 1996; 31: 148-164
66. Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology 2007; 69: 1859-1867
67. Schenck C, Mahowald M. REM sleep behavior disorder: Clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002; 25: 120-138
68. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986; 9: 293-308.
69. Stiasny-Kolster K, Doerr Y, Möller J, Höffken H, Behr T, Oertel W, et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005; 128: 126-137
70. Tang-Wai D, Graff-Radford N, Boeve B, Dickson D, Parisi J, Crook R, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 2004; 63: 1168-1174
71. Tang-Wai DF, Knopman DS, Geda YE, Edland SD, Smith GE, Ivnik RJ, et al. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Arch Neurol 2003; 60: 1777-1781
72. Terzaghi M, Sinforiani E, Zucchella C, Zambrelli E, Pasotti C, Rustioni V, et al. Cognitive performance in REM sleep behaviour disorder: a possible early marker of neurodegenerative disease? Sleep Med 2008; 9: 343-351
73. Togo T, Cookson N, Dickson D. Argyrophilic grain disease: Neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 2002; 12: 45-52.
74. Uchiyama M, Isse K, Tanaka K, Yokota N, Hamamoto H, Aida S, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 1995; 45: 709-712
75. Wechsler D. Wechsler Adult Intelligence Scale-Revised (Manual). San Antonio: The Psychological Corporation; 1981.
76. Wechsler D. Wechsler Memory Scale-Revised (Manual). New York: Psychological Corporation; 1987.
77. Whitwell J, Weigand S, Shiung M, Boeve B, Ferman T, Smith G, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 2007; 130: 708-719